2020
Utilization, financial outcomes and stakeholder perspectives of a re-organized adult sickle cell program
Rousseau R, Weisberg DF, Gorero J, Parwani V, Bozzo J, Kenyon K, Smith C, Cole J, Curtis S, Forray A, Roberts JD. Utilization, financial outcomes and stakeholder perspectives of a re-organized adult sickle cell program. PLOS ONE 2020, 15: e0236360. PMID: 32706825, PMCID: PMC7380627, DOI: 10.1371/journal.pone.0236360.Peer-Reviewed Original ResearchConceptsSickle cell diseaseCell diseaseYale-New Haven HospitalAcute care servicesCare of adultsPoor socio-economic statusPersonalized care planSickle Cell ProgramNew Haven HospitalSingle nursing unitParenteral opioidsPain controlClinic visitsMost patientsPain managementChronic painOutpatient visitsPrimary complaintEmergency departmentPrimary careInpatient daysCare plansCare servicesSocio-economic statusNursing units
2018
Marijuana Use in Adults Living with Sickle Cell Disease
Roberts JD, Spodick J, Cole J, Bozzo J, Curtis S, Forray A. Marijuana Use in Adults Living with Sickle Cell Disease. Cannabis And Cannabinoid Research 2018, 3: 162-165. PMID: 30014039, PMCID: PMC6044416, DOI: 10.1089/can.2018.0001.Peer-Reviewed Original ResearchSickle cell diseaseCell diseaseMedical marijuanaMarijuana useUrine drug testsPossible therapeutic effectsUrine drug testingAcademic medical centerTertiary careTherapeutic effectMedical CenterPatient's requestPatientsDiseaseQualifying conditionsDrug testsDrug testingCannabinoidsActive constituentsMarijuanaMedicinal indicationsPhencyclidineAdultsInstitutional recordsRecreational use
2017
Marijuana use in adults with sickle cell disease
Forray A, Bozzo J, Cole J, Spodick J, Roberts J. Marijuana use in adults with sickle cell disease. Drug And Alcohol Dependence 2017, 171: e64-e65. DOI: 10.1016/j.drugalcdep.2016.08.187.Peer-Reviewed Original Research